Drug Type Small molecule drug |
Synonyms- |
Target |
Action activators, agonists, stimulants |
Mechanism HMOX1 activators(Heme oxygenase 1 activators), KEAP1 agonists(Kelch-like ECH-associated protein 1 agonists), Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H24FN3O |
InChIKeyBQIOUCQSVKJVPP-PFONDFGASA-N |
CAS Registry3065791-05-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Lung Injury | Preclinical | China | 15 Nov 2024 | |
| Lung Injury | Preclinical | China | 15 Nov 2024 |





